# RU Anti-SARS-CoV-2 (COVID-19) mAbs in Healthy Volunteers

> **NCT04700163** · PHASE1 · COMPLETED · sponsor: **Rockefeller University** · enrollment: 23 (actual)

## Conditions studied

- Covid19

## Interventions

- **BIOLOGICAL:** C144-LS and C-135-LS

## Key facts

- **NCT ID:** NCT04700163
- **Lead sponsor:** Rockefeller University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-11
- **Primary completion:** 2022-02-02
- **Final completion:** 2022-02-02
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2025-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04700163

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04700163, "RU Anti-SARS-CoV-2 (COVID-19) mAbs in Healthy Volunteers". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04700163. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*